|
|
|
|
|
by unearthed
2429 days ago
|
|
> "That's the failure point for most biotech startups -- they dont have a useful application of their tech." This is precisely the failure of every academic ever. We can examine this through the Theil-lens where they're trying to create a narrative of uniqueness where their research applies + revolutionizes everything ( when it does not ). But everyone knows this is not the case. This is the central plague of all academic research, that its the pursuit of novel understanding before useful application. I would argue that this is more a defining characteristic of the current academic pyramid scheme than biotech startups. Biotech startups dont go out for VC unless they HAVE a market. Biotech phds go to the NIH regardless of whether theres a market. |
|
Plague of all academic research?! Isn't the point of academic research to understand before application (and quite often application is not the goal at all and that's ok)?
I get that it may seem trivial to apply something, but with high-cost risks of mistakes when they happen in biology/medicine it is not.
The pharma industry learned this the hard way: https://en.wikipedia.org/wiki/Thalidomide
It seems to me that some software engineers/computer scientist think that other fields are slow/full stupid people because the progress is not fast. Well the progress is not fast because cost to start is often huge, wetware can't be moved to cloud, stakes are higher than unhappy customers etc.